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Purpose: Oxidized low-density lipoprotein (ox-LDL) is one of most impor-
tant molecules for pathogenesis of atherosclerosis. Recently, it has been
demonstrated in vitro and vivo studies that lectin-like ox-LDL receptor-1
(LOX-1) expresses on articular chondrocytes and suggested that its
ligand ox-LDL plays some roles in degeneration of articular cartilage
and pathogenesis of osteoarthritis. The purpose of this study is to show
that ox-LDL binding to LOX-1 suppresses telomerase activity in cultured
bovine articular chondrocytes (BACs) through inactivation of the PI3
kinase/Akt pathway.
Methods: Time course and dose response of telomerase activity follow-
ing ox-LDL addition were investigated in primary cultured bovine articular
chondrocytes (BACs, 10 month old) in monolayer with 70% conﬂuence.
The telomerase activity was measured by the stretch PCR (TeloChaser,
TOYOBO Co., Tokyo, Japan). To ascertain whether suppression of telom-
erase activity is attributable to ox-LDL binding to LOX-1, BACs were
preincubated with anti-bovine LOX-1 monoclonal antibody (TS-20) or non-
speciﬁc mouse IgG. Furthermore, telomerase activity was measured after
adding LY294002 (a speciﬁc inhibitor of PI3K) and IGF-1 (an activator of
PI3K) in culture medium to clarify involvement of the PI3K/Akt pathway
to the suppression by ox-LDL. Finally, we investigated using immunoblot
analysis whether ox-LDL addition affects phosphorylation of Akt.
Figure 1. Dose response of inhibition of telomerase activity by ox-LDL
in bovine articular chondrocytes. Cells were treated with various dose of
ox-LDL (10 to 100mg/ml) for 12 h (A). Some plates were pre-incubated
with 40mg/ml anti-LOX-1 antibody (TS-20) (B) or 40 mg/ml non-speciﬁc
mouse IgG as for 30min (C). *P< 0.05, **P< 0.01, n = 4.
Figure 2. Effects of the PI3K/Akt pathway on telomerase activity. Telom-
erase activity was measured 12 h after addition of LY294002 at various
dose (0, 0.05, 0.5 and 1 nM) (A) and 12 h after addition of ox-LDL at
various dose (0, 10, 50 and 100 mg/ml) with IGF-1 (0.1 mu;g/ml) (B).
*P< 0.05, **P< 0.01, n = 4.
Results: Telomerase activity was detectable in proliferating BACs cul-
tured in DMEM with bovine fetal serum. Addition of ox-LDL suppressed
the telomerase activity in a time- and dose-dependent manner (Fig 1).
Pretreatments of cultured BACs with anti-LOX-1 antibody (TS-20) recov-
ered the suppression of telomerase activity caused by ox-LDL addition.
LY294002 suppressed the chondrocyte telomerase activity and IGF-1
reversed the effect of ox-LDL addition on the telomerase activity (Fig 2).
Ox-LDL addition rapidly decreased the amount of phosphorylated Akt
(pAkt) in BACs, whereas native LDL did not. Furthermore, pretreatment
with TS-20 signiﬁcantly recovered the reduction of pAkt caused by ox-LDL
addition.
Conclusions: Increase in mitotic and anabolic activity of chondrocytes
has been indicated in early phase osteoarthritis, where telomerase ac-
tivity of chondrocytes is supposed to be up-regulated by growth factors.
In this study, ox-LDL suppressed the telomerase activity in chondrocytes
through inactivation of the PI3K/Akt, which may play an important role
in failure of repairing responses of chondrocytes and in progression
of cartilage degeneration through cell senescence. Osteoarthritis and
atherosclerosis may have a common pathogenetic molecule, ox-LDL.
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Purpose: Our studies analysing genes regulated in cartilage at the
onset of osteoarthritis (OA) revealed up-regulation of the gene encoding
the protein kinase R (PKR)-activating protein, PACT. We subsequently
showed that PKR is involved in tumour necrosis factor-alpha (TNF-a)
signalling in articular cartilage. The aims of the current study were to
investigate whether treatment of articular cartilage chondrocytes with pro-
inﬂammatory cytokines could induce a degradative phenotype that was
mediated through the PKR signalling pathway.
Methods: Full depth, bovine articular cartilage chondrocytes were har-
vested from the metacarpophalangeal joint of 7-day old calves, plated
at 1×106 cells/well of a 24 well plate and cultured in serum free media
supplemented with ITS and ascorbate-2-phosphate (50mg/ml). Chondro-
cytes were treated with either an oncostatin-M (OSM; 10 ng/ml) and
interleukin-1 (Il-1; 5 ng/ml) combination or TNF-a (20 ng/ml) for 7-days.
To inhibit the activation of PKR, a pharmacological inhibitor of PKR
(an imidazole-oxindole compound from Calbiochem; 1 mM) was added to
duplicate cultures 30 minutes prior to the addition of cytokine treatments.
At the end of the 7-day culture period, media was collected for analysis of
cell death (LDH release) and MMP-9 release (gelatin zymography). Cells
were lysed in 0.9% Triton-X100 and extracts and associated matrix were
analysed for type II collagen (Western blot). Cell number was calculated
by measuring the LDH content of the cell lysate.
Results: A combined treatment of OSM and Il-1 resulted in an increase
in cell number over the 7-days of culture compared to untreated controls
(p< 0.05). The addition of the PKR inhibitor alone to chondrocytes had
no affect on cell number. However, when added prior to the addition of
OSM+Il-1, a signiﬁcant increase in cell number was observed (p< 0.001
vs control; p< 0.05 vs OSM+Il-1 alone). OSM+Il-1 increased the extent of
necrotic cell death occurring in chondrocyte cultures (p< 0.05) which was
unaffected by the addition of the PKR inhibitor. TNF-a had no affect on
the level of necrotic cell death over the 7-days. An increase in proMMP-9
was observed in the media of TNF-a treated chondrocytes which was
completely abolished following PKR inhibition. The production of both pro
and active MMP-9 was upregulated by OSM+Il-1 treatment (p< 0.05) and
this was signiﬁcantly reduced following PKR inhibition (p< 0.05). TNF-a
reduced the amount of type II collagen detected in the cell associated
material (p< 0.05). The addition of the PKR inhibitor prior to treatment with
TNF-a resulted in the restoration of the level of type II collagen (p< 0.001
vs TNF-a alone). Whilst treatment of chondrocytes with OSM+Il-1 resulted
in a marked reduction in the amount of type II collagen detected, pre-
treatment with the PKR inhibitor had no affect.
Conclusions: The pro-inﬂammatory cytokines, OSM and Il-1 in combina-
tion increased proliferation of articular chondrocytes which was further en-
hanced when PKR was inhibited. This implicates a role for the activation
of the PKR pathway in the control of pro-inﬂammatory cytokine-mediated
cell proliferation. OSM in combination with Il-1 also increased the extent of
cell death over the culture period but this was not regulated via PKR. The
expected upregulation of MMP-9 was signiﬁcantly decreased by inhibition
of PKR. Type II collagen was reduced in all cultures treated with the pro-
inﬂammatory cytokines but only TNF-a signalled via PKR to achieve this.
This study provides a mechanism of how pro-inﬂammatory cytokines may
mediate some of the well-established degradative effects that occur in
articular cartilage and implicates PKR as a critical signalling molecule in
arthritis.
